Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study to Investigate the Efficacy and Safety of Two Different Doses of Twice Daily Distal Jejunal-release Dextrose Beads Formulations (APHD 012 and APHD 002) Combined With a Gel Composition, Compared With Two Different Doses of the Placebo Beads Formulations (APHP 012 and APHP 002) Combined With a Gel Composition in Obese Subjects With Weight Related Comorbidities

NCT07008456 is registered in ClinicalTrials.gov with Aphaia Pharma US LLC as lead sponsor.

NCT NCT07008456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07008456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study to Investigate the Efficacy and Safety of Two Different Doses of Twice Daily Distal Jejunal-release Dextrose Beads Formulations (APHD 012 and APHD 002) Combined With a Gel Composition, Compared With Two Different Doses of the Placebo Beads Formulations (APHP 012 and APHP 002) Combined With a Gel Composition in Obese Subjects With Weight Related Comorbidities
Lead sponsor
Aphaia Pharma US LLC
Phase
Phase 2
Overall status
Recruiting
Start date
September 12, 2025
Completion date
July 31, 2026
Enrollment
102 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

obese patients (bmi ≥ 30 kg/m²), obese with comorbidities